Navigation Links
Animal Cell Therapies, Inc. and University of Florida Receive $330k Grant from The Sabes Foundation for Stem Cell Study
Date:2/20/2013

San Diego, CA (PRWEB) February 20, 2013

Animal Cell Therapies, Inc. of San Diego and the University of Florida has received a $330k grant from The Sabes Foundation to fund a study about orthopedic conditions in dogs.

Animal Cell Therapies Inc. is an early stage Veterinary stem cell therapy company whose mission is to deliver a new frontier of stem cell therapies for the treatment of canine orthopedic conditions.

The Sabes Foundation grant will be used to study the potential of mesenchymal stem cells to treat orthopedic conditions in dogs. This research may also be translational across human medicine. The main investigator leading this study will be Dr. Antonio Pozzi, DVM at the University of Florida.

“This grant is fundamental to providing answers about the mechanism of stem cell activity in orthopedic conditions in dogs,” said Dr. Kathryn Petrucci, founder of Animal Cell Therapies, Inc.

“The Sabes Foundation has a special interest and focus in the funding of cutting edge medical research and treatment of animals and humans particularly involving the use of stem cells,” said Robert Sabes of The Sabes Foundation.

The Sabes Foundation was founded by Moe and Esther Sabes in order to enrich the lives of the members of the community through contributions to organizations and people that support that mission. The Foundation’s tradition of giving has continued through the stewardship of Robert and Janet Sabes. The Foundation has continued to support the development of the humanities through a wide variety of gifts and grants to both Jewish and secular causes.

The Sabes Family Foundation looks to enrich communities through supporting a variety of gifts and grants – ranging from the Sabes Jewish Community Center, to the Howard Pulley youth basketball tournament. Through the leadership of Robert Sabes, the Foundation has developed strong financial commitments with unique community assets that serve to culturally enrich our lives. To learn more, go to: sabesfoundation.org.    

About Animal Cell Therapies
Founded in January 2008 in San Diego, California, Animal Cell Therapies Inc. is the manifestation of veterinarian Dr. Kathryn Petrucci, whose vision is to improve the lives of animals through thoughtful research and development, innovation and strategic partnerships. At the company’s California-based stem cell research and development facility, the team is focused on developing and delivering revolutionary cellular treatment and services to their customers. For more information, visit: http://www.actcells.com

Read the full story at http://www.prweb.com/releases/2013/2/prweb10429271.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Researchers develop a new cell and animal model of inflammatory breast cancer
2. FDA Seeks to Limit Antibiotics in Animal Feed
3. Animals More Interesting to Kids Than Toys, Study Shows
4. Raucous Music May Tap Into Your Inner Animal
5. Recruiting for Good Launches Pet Philanthropy Program to Collaboratively Fundraise for Kitt Crusaders an Animal Rescue Organization
6. Woodbridge Animal Hospital Unleashes New Pet Care Website
7. Chicago Dog Bite Injury Lawyers Advise Dog Owners To Get Control of Their Animals, Or Be Prepared To Pay Up
8. New technique could reduce number of animals needed to test chemical safety
9. Potential treatment target identified in an animal model of pancreatic cancer
10. New animal model may lead to treatments for common liver disease
11. Lab-engineered muscle implants restore function in animals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: